Report cover image

Global Thyroid Gland Disorder Treatment Market Growth, Size, Trends Analysis - By Indication, By Drug, By Distribution Channel, By Route of Administration - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Publisher SPER Market Research Pvt. Ltd.
Published May 22, 2025
Length 240 Pages
SKU # SPER20187027

Description

Thyroid Gland Disorder Treatment Market Introduction and Overview

According to SPER market research, ‘Global Thyroid Gland Disorder Treatment Market Size- By Indication, By Drug, By Distribution Channel, By Route of Administration – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Global Thyroid Gland Disorder Treatment Market is predicted to reach 3.37 billion by 2034 with a CAGR of 3.85%.

Thyroid gland disease treatment includes medical procedures and therapies designed to manage thyroid gland conditions. The thyroid gland, located in the front of the neck, regulates several biological activities by producing thyroid hormones, most notably thyroxine (T4) and triiodothyronine (T3). Thyroid problems, which include hypothyroidism, hyperthyroidism, Graves’ disease, thyroid nodules, thyroiditis, and thyroid cancer, are on the rise globally due to a variety of causes such as aging populations, environmental impacts, and lifestyle changes.

Restraints:

Limited access to healthcare services is a major challenge for treating thyroid gland disorders worldwide, especially in low- and middle-income countries. Many people with thyroid issues like hypothyroidism, hyperthyroidism, and thyroid nodules find it hard to get timely diagnosis and treatment due to poor healthcare facilities.

Scope of the report:

Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034
Segments covered By Indication, By Drug, By Distribution Channel, By Route of Administration

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered

Abbvie Inc, Amgen Inc, GSK Plc, Merck KGaA, Viatris Inc, Novartis AG, Pfizer Inc, Takeda Pharmaceutical Company Limited, Elexis Inc, IBSA Pharma (IBSA Group).

Global Thyroid Gland Disorder Treatment Market Segmentation:

By Indication: Based on the Indication, Global Thyroid Gland Disorder Treatment Market is segmented as; Hypothyroidism, Hyperthyroidism.

By Drug: Based on the Drug, Global Thyroid Gland Disorder Treatment Market is segmented as; Levothyroxine, Liothyronine, Propylthiouracil, Imidazole-based compounds, Others.

By Distribution Channel:

Based on the Distribution Channel, Global Thyroid Gland Disorder Treatment Market is segmented as; Wholesale Distribution, Retail Stores, Online Pharmacy.

By Route of Administration: Based on the Route of Administration, Global Thyroid Gland Disorder Treatment Market is segmented as; Oral, Intravenous, Others.

By Region:

This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Table of Contents

240 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Thyroid Gland Disorder Treatment Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Thyroid Gland Disorder Treatment Market
7. Global Thyroid Gland Disorder Treatment Market, By Indication (USD Million) 2021-2034
7.1. Hypothyroidism
7.2. Hyperthyroidism
8. Global Thyroid Gland Disorder Treatment Market, By Drug (USD Million) 2021-2034
8.1. Levothyroxine
8.2. Liothyronine
8.3. Propylthiouracil
8.4. Imidazole-based compounds
8.5. Others
9. Global Thyroid Gland Disorder Treatment Market, By Distribution Channel (USD Million) 2021-2034
9.1. Wholesale Distribution
9.2. Retail Stores
9.3. Online Pharmacy
10. Global Thyroid Gland Disorder Treatment Market, By Route of Administration (USD Million) 2021-2034
10.1. Oral
10.2. Intravenous
10.3. Others
11. Global Thyroid Gland Disorder Treatment Market, (USD Million) 2021-2034
11.1. Global Thyroid Gland Disorder Treatment Market Size and Market Share
12. Global Thyroid Gland Disorder Treatment Market, By Region, (USD Million) 2021-2034
12.1. Asia-Pacific
12.1.1. Australia
12.1.2. China
12.1.3. India
12.1.4. Japan
12.1.5. South Korea
12.1.6. Rest of Asia-Pacific
12.2. Europe
12.2.1. France
12.2.2. Germany
12.2.3. Italy
12.2.4. Spain
12.2.5. United Kingdom
12.2.6. Rest of Europe
12.3. Middle East and Africa
12.3.1. Kingdom of Saudi Arabia
12.3.2. United Arab Emirates
12.3.3. Qatar
12.3.4. South Africa
12.3.5. Egypt
12.3.6. Morocco
12.3.7. Nigeria
12.3.8. Rest of Middle-East and Africa
12.4. North America
12.4.1. Canada
12.4.2. Mexico
12.4.3. United States
12.5. Latin America
12.5.1. Argentina
12.5.2. Brazil
12.5.3. Rest of Latin America
13. Company Profile
13.1. Abbvie Inc
13.1.1. Company details
13.1.2. Financial outlook
13.1.3. Product summary
13.1.4. Recent developments
13.2. Amgen Inc
13.2.1. Company details
13.2.2. Financial outlook
13.2.3. Product summary
13.2.4. Recent developments
13.3. GSK Plc
13.3.1. Company details
13.3.2. Financial outlook
13.3.3. Product summary
13.3.4. Recent developments
13.4. Merck KGaA
13.4.1. Company details
13.4.2. Financial outlook
13.4.3. Product summary
13.4.4. Recent developments
13.5. Viatris Inc
13.5.1. Company details
13.5.2. Financial outlook
13.5.3. Product summary
13.5.4. Recent developments
13.6. Novartis AG
13.6.1. Company details
13.6.2. Financial outlook
13.6.3. Product summary
13.6.4. Recent developments
13.7. Pfizer Inc
13.7.1. Company details
13.7.2. Financial outlook
13.7.3. Product summary
13.7.4. Recent developments
13.8. Takeda Pharmaceutical Company Limited
13.8.1. Company details
13.8.2. Financial outlook
13.8.3. Product summary
13.8.4. Recent developments
13.9. Elexis Inc
13.9.1. Company details
13.9.2. Financial outlook
13.9.3. Product summary
13.9.4. Recent developments
13.10. IBSA Pharma (IBSA Group)
13.10.1. Company details
13.10.2. Financial outlook
13.10.3. Product summary
13.10.4. Recent developments
13.11. Others
14. Conclusion
15. List of Abbreviations
16. Reference Links

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us